RecruitingNCT06476145
Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation
Prospective Randomized Controlled Trial Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation
Sponsor
AdventHealth
Enrollment
342 participants
Start Date
Dec 8, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking (EMR-MM) and endoscopic mucosal resection with thermal margin ablation (EMR-STSC)
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age 18 years or older
- Ability to provide informed consent
- Patient scheduled to undergo colonoscopy for the evaluation and removal of colon polyps
- Non-pedunculated polyps ≥ 20 mm size
Exclusion Criteria6
- Pedunculated polyps
- Inflammatory bowel disease
- Inability to provide informed consent
- Lesions < 20 mm in size (largest dimension)
- Lesion involves the lips of the ileocecal valve, is located at the appendiceal orifice and/or is fully circumferential.
- Any standard contraindication, including pregnancy, to anesthesia and/or colonoscopy
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06476145
Related Trials
Clinical Evaluation of a New Platform for Bi-manual Endoscopic Resection in the Rectum and Sigma (EndoTEM)
NCT071461653 locations
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
NCT068224134 locations
Artificial Intelligence-assisted System in Colonoscopy
NCT064060621 location
Prospective Study of EndoAim: ASUS AI Solution for Colorectal Polyp Diagnosis
NCT066563121 location